Algo version: 0.98b
AIM Vaccine Co Ltd is listed at the HKSE Exchange
AIM Vaccine Co Ltd [6660.HK]
HKSE Sector: Healthcare Industry:Biotechnology

Is AIM Vaccine Co Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for AIM Vaccine Co Ltd 10 years ago, but if you had invested on Thursday 6th of October 2022 when the price was HKD16.66, you would have made a loss of HKD-9.64 per share or -57.86%

Yes, the average daily trading liquidity for AIM Vaccine Co Ltd is HKD6.00 million. You should therefore be able to get in and out of your positions relatively fast.

AIM Vaccine Co Ltd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for AIM Vaccine Co Ltd to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.